US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Articles published by DBV Technologies S.A.

< Previous 1 2 3 4 Next >
News headline image
DBV Technologies to Participate in the Citizens JMP Life Sciences Conference
From DBV Technologies S.A.
Via GlobeNewswire
Tickers DBVT
News headline image
DBV Technologies Reports First Quarter 2025 Financial Results
From DBV Technologies S.A.
Via GlobeNewswire
Tickers DBVT
News headline image
DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document
From DBV Technologies S.A.
Via GlobeNewswire
Tickers DBVT
News headline image
DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved
From DBV Technologies S.A.
Via GlobeNewswire
Tickers DBVT
News headline image
DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin® Peanut Patch in 4–7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, & Reports 2024 Unaudited Financial Results...
From DBV Technologies S.A.
Via GlobeNewswire
Tickers DBVT
News headline image
DBV Technologies to Participate in Upcoming AAAAI/WAO Joint Congress
From DBV Technologies S.A.
Via GlobeNewswire
Tickers DBVT
News headline image
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
From DBV Technologies S.A.
Via GlobeNewswire
Tickers DBVT
News headline image
DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study
From DBV Technologies S.A.
Via GlobeNewswire
Tickers DBVT
News headline image
DBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 1 – 3 Years-Old
From DBV Technologies S.A.
Via GlobeNewswire
Tickers DBVT
News headline image
Information regarding the total number of voting rights and  total number of shares of the Company as of November 30, 2024
From DBV Technologies S.A.
Via GlobeNewswire
Tickers DBVT
News headline image
DBV Technologies Announces Plan to Implement ADS Ratio Change
From DBV Technologies S.A.
Via GlobeNewswire
Tickers DBVT
News headline image
DBV Technologies Reports Third Quarter 2024 Financial Results
From DBV Technologies S.A.
Via GlobeNewswire
Tickers DBVT
News headline image
DBV Announces Positive Regulatory Updates for the Viaskin® Peanut Patch in the United States and Europe
From DBV Technologies S.A.
Via GlobeNewswire
Tickers DBVT
News headline image
DBV Technologies to Participate in Upcoming ACAAI 2024 Congress
From DBV Technologies S.A.
Via GlobeNewswire
Tickers DBVT
News headline image
Information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2024
From DBV Technologies S.A.
Via GlobeNewswire
Tickers DBVT
News headline image
DBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial
From DBV Technologies S.A.
Via GlobeNewswire
Tickers DBVT
News headline image
DBV Technologies to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
From DBV Technologies S.A.
Via GlobeNewswire
Tickers DBVT
News headline image
Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2024
From DBV Technologies S.A.
Via GlobeNewswire
Tickers DBVT
News headline image
DBV Technologies Announces Filing of 2024 Half-Year Report ― Conditions for Accessing or Consulting the Report
From DBV Technologies S.A.
Via GlobeNewswire
Tickers DBVT
News headline image
DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results
From DBV Technologies S.A.
Via GlobeNewswire
Tickers DBVT
News headline image
DBV Technologies to Report Second Quarter 2024 Financial Results and Business Update on July 30, 2024
From DBV Technologies S.A.
Via GlobeNewswire
Tickers DBVT
News headline image
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
From DBV Technologies S.A.
Via GlobeNewswire
Tickers DBVT
News headline image
DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
From DBV Technologies S.A.
Via GlobeNewswire
Tickers DBVT
News headline image
Information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2024
From DBV Technologies S.A.
Via GlobeNewswire
Tickers DBVT
News headline image
DBV Technologies Announces Plan to Implement ADS Ratio Change
From DBV Technologies S.A.
Via GlobeNewswire
Tickers DBVT
News headline image
DBV Technologies to Participate in Upcoming EAACI 2024 Congress
From DBV Technologies S.A.
Via GlobeNewswire
Tickers DBVT
News headline image
DBV Technologies Announces Plan to Implement ADS Ratio Change
From DBV Technologies S.A.
Via GlobeNewswire
Tickers DBVT
News headline image
DBV Technologies Announces Results of its 2024 Combined General Meeting
From DBV Technologies S.A.
Via GlobeNewswire
Tickers DBVT
News headline image
DBV Technologies to Participate in Upcoming Investor Conferences
From DBV Technologies S.A.
Via GlobeNewswire
Tickers DBVT
News headline image
DBV Technologies Reports First Quarter 2024 Financial Results and Business Update
From DBV Technologies S.A.
Via GlobeNewswire
Tickers DBVT
< Previous 1 2 3 4 Next >